IDH2 and oligodendroglioma: IDH mutations are seen in 73% of secondary glioblastomas but only 3.7% of primary glioblastoma suggesting malignant transformation of lower grade IDH mutant astrocytoma and oligodendroglioma (Han et al., 2020).